Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

HPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesions.

Mehlhorn G, Hautmann SK, Koch MC, Strehl JD, Hartmann A, Hilfrich R, Beckmann MW, Griesser H.

Anticancer Res. 2014 Sep;34(9):5127-32.

PMID:
25202103
2.

Macrocyclic protease inhibitors with reduced peptide character.

Chua KC, Pietsch M, Zhang X, Hautmann S, Chan HY, Bruning JB, Gütschow M, Abell AD.

Angew Chem Int Ed Engl. 2014 Jul 21;53(30):7828-31. doi: 10.1002/anie.201404301. Epub 2014 Jun 5.

PMID:
24903745
3.

Synthesis and evaluation of 2-(1H-indol-3-yl)-4-phenylquinolines as inhibitors of cholesterol esterase.

Muscia GC, Hautmann S, Buldain GY, Asís SE, Gütschow M.

Bioorg Med Chem Lett. 2014 Mar 15;24(6):1545-9. doi: 10.1016/j.bmcl.2014.01.081. Epub 2014 Feb 7.

PMID:
24556381
4.

ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion.

Hautmann RE, Abol-Enein H, Davidsson T, Gudjonsson S, Hautmann SH, Holm HV, Lee CT, Liedberg F, Madersbacher S, Manoharan M, Mansson W, Mills RD, Penson DF, Skinner EC, Stein R, Studer UE, Thueroff JW, Turner WH, Volkmer BG, Xu A; International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012.

Eur Urol. 2013 Jan;63(1):67-80. doi: 10.1016/j.eururo.2012.08.050. Epub 2012 Aug 31. Review.

PMID:
22995974
5.

[Secondary malignancies in urinary diversions].

Kälble T, Hofmann I, Thüroff JW, Stein R, Hautmann R, Riedmiller H, Vergho D, Hertle L, Wülfing C, Truß M, Roth S, von Rundstedt FC, Albers P, Gschwend J, Herkommer K, Humke U, Spahn M, Bader P, Steffens J, Harzmann R, Stief CG, Karl A, Müller SC, Waldner M, Noldus J, Kleinschmidt K, Alken P, Kopper B, Fisch M, Lampel A, Stenzel A, Fichtner J, Flath B, Rübben H, Juenemann KP, Hautmann S, Knipper A, Leusmann D, Strohmaier W, Thon WF, Miller S, Weingärtner K, Schilling A, Piechota H, Becht JE, Schwaibold H, Bub P, Conrad S, Wenderoth U, Merkle W, Rösch W, Otto T, Ulshöfer B, Westenfelder M.

Urologe A. 2012 Apr;51(4):500, 502-6. doi: 10.1007/s00120-012-2815-8. German.

PMID:
22476801
6.

New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffolds.

Heng S, Tieu W, Hautmann S, Kuan K, Pedersen DS, Pietsch M, Gütschow M, Abell AD.

Bioorg Med Chem. 2011 Dec 15;19(24):7453-63. doi: 10.1016/j.bmc.2011.10.042. Epub 2011 Oct 20.

PMID:
22075233
7.

Complications associated with urinary diversion.

Hautmann RE, Hautmann SH, Hautmann O.

Nat Rev Urol. 2011 Nov 1;8(12):667-77. doi: 10.1038/nrurol.2011.147. Review.

PMID:
22045349
8.

[HPV-associated alterations of the vulva and vagina. Morphology and molecular pathology].

Horn LC, Klostermann K, Hautmann S, Höhn AK, Beckmann MW, Mehlhorn G.

Pathologe. 2011 Nov;32(6):467-75. doi: 10.1007/s00292-011-1476-5. Review. German.

PMID:
22038133
9.

Inhibition of human leukocyte elastase by brunsvicamides a-C: cyanobacterial cyclic peptides.

Sisay MT, Hautmann S, Mehner C, König GM, Bajorath J, Gütschow M.

ChemMedChem. 2009 Sep;4(9):1425-9. doi: 10.1002/cmdc.200900139. No abstract available.

PMID:
19569166
10.

[Urine-based diagnostics: an update on the Kiel Tumor Bank].

Hautmann S, Lokeshwar VB, Juenemann KP.

Urologe A. 2009 Jun;48(6):619-24. doi: 10.1007/s00120-009-1991-7. Review. German.

PMID:
19557467
11.

New peptolides from the cyanobacterium Nostoc insulare as selective and potent inhibitors of human leukocyte elastase.

Mehner C, Müller D, Kehraus S, Hautmann S, Gütschow M, König GM.

Chembiochem. 2008 Nov 3;9(16):2692-703. doi: 10.1002/cbic.200800415.

PMID:
18924217
12.

[Brachytherapy of the prostate cancer].

Stübinger SH, Wilhelm R, Kaufmann S, Döring M, Hautmann S, Jünemann KP, Galalae R.

Urologe A. 2008 Mar;47(3):284-90. doi: 10.1007/s00120-008-1634-4. German.

PMID:
18286255
13.

Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil.

Bannowsky A, Schulze H, van der Horst C, Hautmann S, Jünemann KP.

BJU Int. 2008 May;101(10):1279-83. doi: 10.1111/j.1464-410X.2008.07515.x. Epub 2008 Feb 18.

14.

[Extended sentinel lymph node dissection in radical prostatectomy for prostate cancer: a study in the Kiel risk population].

Hautmann S, Beitz S, Naumann M, Lützen U, Seif C, Stübinger SH, van der Horst C, Braun PM, Leuschner I, Henze E, Jünemann KP.

Urologe A. 2008 Mar;47(3):299-303. doi: 10.1007/s00120-008-1652-2. German.

PMID:
18273596
15.

[Prostate cancer -- quo vadis? Surgery, radiation therapy, or active monitoring?].

Hautmann S.

Urologe A. 2008 Mar;47(3):259-60. doi: 10.1007/s00120-008-1635-3. German. No abstract available.

PMID:
18251000
16.

[Tumor markers for bladder cancer: up-to-date study by the Kiel Tumor Bank].

Hautmann S, Eggers J, Meyhoff H, Melchior D, Munk A, Hamann M, Naumann M, Braun PM, Jünemann KP.

Urologe A. 2007 Nov;46(11):1508-13. German.

PMID:
17932643
17.

[Sentinels and markers: new methods of examination and treatment in urology].

Hautmann S.

Urologe A. 2007 Nov;46(11):1483-4. German. No abstract available.

PMID:
17926017
18.

[30 Years of sentinel lymph node diagnostic in penile carcinoma: development of a diagnostic procedure and current results].

Naumann CM, Hamann MF, Wefer B, Kaufmann S, Al Najar A, Seif C, Braun PM, Hautmann S, Jünemann KP, van der Horst C.

Urologe A. 2007 Nov;46(11):1514-8. German.

PMID:
17926016
19.

[Mesonephroid carcinoma of the urinary bladder (clear cell carcinoma). Two case reports and review of the literature in a rare variation of the primary adenocarcinoma].

Bannowsky A, Wefer B, Osmonov D, Sotelino JA, Filippow N, Naumann CM, van der Horst Ch, Jünemann KP, Hautmann S.

Aktuelle Urol. 2007 May;38(3):247-51. Review. German.

PMID:
17516385
20.

[Functional outcome after laser vaporisation of the prostate with the KTP laser].

Hamann MF, Wild C, Seif C, Hautmann S, Jünemann KP, Braun PM.

Urologe A. 2007 May;46(5):521-4, 526-7. German.

PMID:
17372716
21.

HAS1 expression in bladder cancer and its relation to urinary HA test.

Golshani R, Hautmann SH, Estrella V, Cohen BL, Kyle CC, Manoharan M, Jorda M, Soloway MS, Lokeshwar VB.

Int J Cancer. 2007 Apr 15;120(8):1712-20.

22.

[Sarcomatoid renal cell carcinoma. A rare and aggressive variation of primary renal cell carcinoma].

Bannowsky A, Leuschner I, Schiller H, Bothe K, Osmonov D, Jünemann KP, Hautmann S.

Urologe A. 2007 Apr;46(4):406-11. German.

PMID:
17160666
23.

[The influence of the T stage on the risk of metastasis of penis cancer: T1 vs. T2].

Naumann CM, van der Horst C, Volkmer B, Kurtz F, Martinéz Portillo FJ, Seif C, Hautmann S, Braun PM, Hautmann R, Jünemann KP.

Urologe A. 2006 Nov;45(11):1424, 1426-30. German.

PMID:
16906416
24.

[Urinary cytology. Possibilities, limitations and the future].

Zaak D, Tritschler S, Knuechel R, Vom Dorp F, Hakenberg OW, Hautmann S, Rübben H.

Urologe A. 2006 Sep;45 Suppl 4:97-101. Review. German.

PMID:
16821054
25.

Refluxing chimney versus nonrefluxing LeDuc ureteroileal anastomosis for orthotopic ileal neobladder: a comparative analysis for patients with bladder cancer.

Hautmann S, Chun KH, Currlin E, Braun P, Huland H, Juenemann KP.

J Urol. 2006 Apr;175(4):1389-93; discussion 1393-4.

PMID:
16516005
26.

Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers.

Habuchi T, Marberger M, Droller MJ, Hemstreet GP 3rd, Grossman HB, Schalken JA, Schmitz-Dräger BJ, Murphy WM, Bono AV, Goebell P, Getzenberg RH, Hautmann SH, Messing E, Fradet Y, Lokeshwar VB.

Urology. 2005 Dec;66(6 Suppl 1):64-74.

PMID:
16399416
27.

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers.

Lokeshwar VB, Habuchi T, Grossman HB, Murphy WM, Hautmann SH, Hemstreet GP 3rd, Bono AV, Getzenberg RH, Goebell P, Schmitz-Dräger BJ, Schalken JA, Fradet Y, Marberger M, Messing E, Droller MJ.

Urology. 2005 Dec;66(6 Suppl 1):35-63.

PMID:
16399415
28.

[Decreased number of R1-resections in radical retropubic prostatectomy. Use of a newly developed fast sectioning technique].

Braun PM, Meyer-Schell K, Seif C, Hautmann S, Leuschner I, Klöppel G, Jünemann KP.

Urologe A. 2005 Nov;44(11):1324-31. German.

PMID:
16133227
30.

Extracorporeal shockwave lithotripsy compared with ureteroscopy for the removal of small distal ureteral stones.

Hautmann S, Friedrich MG, Fernandez S, Steuber T, Hammerer P, Braun PM, Jünemann KP, Huland H.

Urol Int. 2004;73(3):238-43.

PMID:
15539843
31.

Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.

Hautmann S, Toma M, Lorenzo Gomez MF, Friedrich MG, Jaekel T, Michl U, Schroeder GL, Huland H, Juenemann KP, Lokeshwar VB.

Eur Urol. 2004 Oct;46(4):466-71.

PMID:
15363562
32.

A side by side comparison of cytology and biomarkers for bladder cancer detection.

Schroeder GL, Lorenzo-Gomez MF, Hautmann SH, Friedrich MG, Ekici S, Huland H, Lokeshwar V.

J Urol. 2004 Sep;172(3):1123-6.

PMID:
15311054
33.

Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer.

Toma MI, Friedrich MG, Hautmann SH, Jäkel KT, Erbersdobler A, Hellstern A, Huland H.

World J Urol. 2004 Jun;22(2):145-9. Epub 2004 Feb 27.

PMID:
14991320
34.

[Cystectomy for indications other than bladder cancer].

Hautmann S, Felix-Chun KH, Currlin E, Friedrich MG, Dose Schwarz J, Langwieler T, Conrad S, Huland H.

Urologe A. 2004 Feb;43(2):172-7. German.

PMID:
14991119
35.
36.

[Suprarenal leiomyoma of the vena cava. A rare differential adrenal gland tumor diagnosis].

Friedrich MG, Witte A, Hautmann SH, Saeger W.

Urologe A. 2002 Nov;41(6):611-3. German.

PMID:
12524949
37.
38.

Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests.

Lokeshwar VB, Schroeder GL, Selzer MG, Hautmann SH, Posey JT, Duncan RC, Watson R, Rose L, Markowitz S, Soloway MS.

Cancer. 2002 Jul 1;95(1):61-72.

39.

Hyaluronic Acid and Hyaluronidase: Accurate Tumor Markers and Tumor Progression Regulators.

Lokeshwar V, Schroeder G, Hautmann S, Selzer M.

ScientificWorldJournal. 2001 Oct 23;1:106. doi: 10.1100/tsw.2001.120. eCollection 2001. No abstract available.

40.

Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer.

Hautmann SH, Lokeshwar VB, Schroeder GL, Civantos F, Duncan RC, Gnann R, Friedrich MG, Soloway MS.

J Urol. 2001 Jun;165(6 Pt 1):2068-74.

PMID:
11371930
41.

High-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens.

Prange W, Erbersdobler A, Hammerer P, Graefen M, Hautmann SH, Hautmann RE, Huland H, Henke RP.

Eur Urol. 2001 Apr;39 Suppl 4:30-1. No abstract available.

PMID:
11340284
42.

Detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients.

Conrad S, Hautmann SH, Henke RP, Erbersdobler A, Simon J, Straub M, Graefen M, Hautmann RE, Huland H.

Eur Urol. 2001 Apr;39 Suppl 4:25-9. No abstract available.

PMID:
11340283
43.

[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers].

Hautmann SH, Schroeder GL, Civantos F, Duncan RC, Gnann R, Friedrich MG, Hellstern A, Huland H, Soloway MS, Lokeshwar VB.

Urologe A. 2001 Mar;40(2):121-6. German.

PMID:
11315586
44.

Significance of high-grade prostatic intraepithelial neoplasia in needle biopsy specimens.

Prange W, Erbersdobler A, Hammerer P, Graefen M, Hautmann SH, Hautmann RE, Huland H, Henke RP.

Urology. 2001 Mar;57(3):486-90.

PMID:
11248625
45.

Treatment of metastatic hormone-refractory prostate adenocarcinoma (MatLyLu) in Copenhagen rats with micro-osmotic interleukin-2 pumps.

Hautmann S, Huland E, Wullbrand A, Friedrich M, Huland H.

Anticancer Res. 2000 Nov-Dec;20(6B):4495-8.

PMID:
11205294
46.

Super-sensitive prostate-specific antigen (PSA) in serum of women with benign breast disease or breast cancer.

Hautmann S, Huland E, Grupp C, Haese A, Huland H.

Anticancer Res. 2000 May-Jun;20(3B):2151-4.

PMID:
10928169
47.

Detection rate of histologically insignificant prostate cancer with systematic sextant biopsies and fine needle aspiration cytology.

Hautmann SH, Conrad S, Henke RP, Erbersdobler A, Simon J, Straub M, Graefen M, Hautmann RE, Huland H.

J Urol. 2000 Jun;163(6):1734-8.

PMID:
10799171
48.

Local intratumor immunotherapy of prostate cancer with interleukin-2 reduces tumor growth.

Hautmann SH, Huland E, Huland H.

Anticancer Res. 1999 Jul-Aug;19(4A):2661-3.

PMID:
10470215
49.

Supplemental Content

Loading ...
Support Center